BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6163874)

  • 1. Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells.
    Czarniecki CW; Sreevalsan T; Friedman RM; Panet A
    J Virol; 1981 Feb; 37(2):827-31. PubMed ID: 6163874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma.
    Hochman J; Mador N; Gloger I; Falk H; Panet A
    Exp Cell Res; 1988 Jul; 177(1):37-46. PubMed ID: 2455652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antiviral effects of interferon in three murine cell lines.
    Sen GC; Herz RE
    J Virol; 1983 Mar; 45(3):1017-27. PubMed ID: 6187940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of interferon-sensitive cells derived from an interferon-resistant NIH 3T3 line.
    Mittnacht S; Jacobsen H
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2945-51. PubMed ID: 2445907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociable antiviral activities directed against cardioviruses are expressed in L cells treated with interferon.
    Monahan SJ; Simon E
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2299-303. PubMed ID: 1383407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of procaine and oxyphenylbutazone on interferon-mediated inhibition of murine leukemia virus production.
    Herz RE; Sen GC
    Antiviral Res; 1983 Sep; 3(3):189-94. PubMed ID: 6197028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue and transmission of a replication-defective variant of moloney murine leukemia virus.
    Rein A; Benjers BM; Gerwin BI; Bassin RH; Slocum DR
    J Virol; 1979 Feb; 29(2):494-500. PubMed ID: 219244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
    Evans LH; Morrey JD
    J Virol; 1987 May; 61(5):1350-7. PubMed ID: 3033265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon on assembly of intracellular Moloney murine leukemia virus particles in chronically infected 3T3/NIH cells.
    Aboud M; Hassan Y; Huleihel M
    Arch Virol; 1982; 74(4):249-58. PubMed ID: 6187315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus.
    Peebles PT; Bassin RH; Haapala DK; Phillips LA; Nomura S; Fischinger PJ
    J Virol; 1971 Nov; 8(5):690-4. PubMed ID: 4332138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity.
    Epstein DA; Czarniecki CW; Jacobsen H; Friedman RM; Panet A
    Eur J Biochem; 1981 Aug; 118(1):9-15. PubMed ID: 6169526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
    Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization.
    Rein AL; Gerwin BI; Bassin RH; Schwarm L; Schidlovsky G
    J Virol; 1978 Jan; 25(1):146-56. PubMed ID: 74421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein synthesis and membrane integrity in interferon-treated HeLa cells infected with encephalomyocarditis virus.
    Muñoz A; Carrasco L
    J Gen Virol; 1981 Sep; 56(Pt 1):153-62. PubMed ID: 6170728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression by Moloney leukemia virus: lack of correlation between virus replication and the immunosuppressive effect.
    Cerny J; Proffitt MR; Essex M
    J Natl Cancer Inst; 1976 Apr; 56(4):819-22. PubMed ID: 768506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.
    Fan H; Jaenisch R; MacIsaac P
    J Virol; 1978 Dec; 28(3):802-9. PubMed ID: 731793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
    Brightman BK; Pattengale PK; Fan H
    J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.
    Whitaker-Dowling P; Youngner JS
    Virology; 1986 Jul; 152(1):50-7. PubMed ID: 2424172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.